Skip to main content

Table 3 Number of subjects per medication type

From: Does CRP predict outcome in bipolar disorder in regular outpatient care?

Parameter T0a T1b Totalc
Lithium (%) 31 (36.9) 47 (56) 48 (57.1)
Valproic acid (%) 14 (16.7) 9 (10.7) 16 (19.0)
Anti-inflammatory drugs (%)d 12 (14.3) 12 (14.3) 16 (19.0)
Tricyclic antidepressants (TCA) (%)d 5 (6) 5 (6) 7 (8.3)
Antidepressants (non-TCA) (%) 31 (36.9) 27 (32.1) 32 (38.1)
Antipsychotics (%) 35 (41.7) 34 (40.5) 39 (46.4)
Benzodiazepines (%) 31 (36.9) 31 (36.9) 39 (46.4)
  1. aMedication used up to and including the baseline (T0)
  2. bMedication used up to and including the time of episode change is such occurred (T1)
  3. cMedication used for the total period of the study (1 month before and up to 15 months after CRP measurement, unless episode change occurred earlier)
  4. dValues are the same for both T0 and T1 timepoints